tiprankstipranks
Advertisement
Advertisement
Carlisle price target lowered to $43 from $44 at Baird
PremiumThe FlyCarlisle price target lowered to $43 from $44 at Baird
27d ago
Castle Biosciences: Buy Rating Reiterated as Strong Q1, Raised 2026 Outlook and Unchanged $40 Price Target Underscore Undervaluation
Premium
Ratings
Castle Biosciences: Buy Rating Reiterated as Strong Q1, Raised 2026 Outlook and Unchanged $40 Price Target Underscore Undervaluation
27d ago
Castle Biosciences reports Q1 EPS , consensus (49c)
Premium
The Fly
Castle Biosciences reports Q1 EPS , consensus (49c)
28d ago
Castle announces publication of DecisionDx-Melanoma’s i31-SLNB study results
PremiumThe FlyCastle announces publication of DecisionDx-Melanoma’s i31-SLNB study results
3M ago
Castle Biosciences announces new data from study evaluating i31SLNB
Premium
The Fly
Castle Biosciences announces new data from study evaluating i31SLNB
3M ago
Castle Biosciences Balances Strong Growth With Margin Strain
Premium
Company Announcements
Castle Biosciences Balances Strong Growth With Margin Strain
3M ago
Castle Biosciences Posts Modest 2025 Growth Amid Headwinds
PremiumCompany AnnouncementsCastle Biosciences Posts Modest 2025 Growth Amid Headwinds
3M ago
Castle Biosciences price target raised to $50 from $36 at KeyBanc
Premium
The Fly
Castle Biosciences price target raised to $50 from $36 at KeyBanc
4M ago
Castle Biosciences price target raised to $47 from $43 at Guggenheim
Premium
The Fly
Castle Biosciences price target raised to $47 from $43 at Guggenheim
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100